Effect of inhaled glucocorticoids and β2 agonists on vertebral fracture risk in COPD patients: The EOLO study

Calcified Tissue International

Volumn 87, Issue 2, 2010, Pages 137-143

  Gonnelli, S ^a   Caffarelli, C ^a   Maggi, S ^b   Guglielmi, G ^c   Siviero, P ^b   Rossi, S ^a   Crepaldi, G ^b   Nuti, R ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Scientific Institute   (Italy)

Author keywords

2 agonist; COPD; Inhaled glucocorticoid; QUS; Vertebral fracture

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID;

AGED; ARTICLE; BONE; CHEMICALLY INDUCED DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DRUG EFFECT; EPIDEMIOLOGY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; OSTEOPOROSIS; RISK; SPINE FRACTURE;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; BONE AND BONES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; SPINAL FRACTURES;

EID: 79952111554     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-010-9392-x     Document Type: Article

References (30)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ et al (2007) Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532-555
2. Wouters EFM, Celis MP, Breyer MK et al (2007) Co-morbid manifestations in COPD. Respir Med COPD Update 3:135-151
3. Biskobing DM (2002) COPD and osteoporosis. Chest 121:609-620
4. Ferguson GT, Calverley PM, Anderson JA et al (2009) Prevalence and progression of osteoporosis in patients with COPD: Results from the towards a revolution in COPD health study. Chest 136:1456-1465
5. Graat-Verboom L, Spruit MA, van den Borne BE et al (2009) Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component. Respir Med 103:1143-1151
6. Kjensli A, Mowinckel P, Ryg MS, Falch JA (2007) Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone 40:493-497
7. Nuti R, Siviero P, Maggi S et al (2009) Vertebral fractures in patients with chronic obstructive pulmonary disease: The EOLO Study. Osteoporos Int 20:989-998
8. Jørgensen NR, Schwarz P, Holme I et al (2007) The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: A cross sectional study. Respir Med 101:177-185
9. Dam TT, Harrison S, Fink HA et al (2009) Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporos Int. doi:10.1007/s00198-009-1076-x
10. de Vries F, Bracke M, Leufkens HG et al (2007) Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56:208-214
11. van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis. Osteoporos Int 13:777-787
12. van Staa TP, Leufkens B, Cooper C (2009) Bone loss and inhaled glucocorticoids. N Engl J Med 346:533-535
13. Langhammer A, Forsmo S, Syversen U (2009) Long-term therapy in COPD: Any evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis 4:365-380
14. Richy F, Bousquet J, Ehrlich GE et al (2003) Inhaled corticosteroids effects on bone in asthmatic and COPD patients: A quantitative systematic review. Osteoporos Int 14:179-190
15. Scanlon PD, Connett JE, Wise RA, Group Lung Health Study Research et al (2004) Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med 170:1302-1309
16. Hubbard R, Tattersfield A, Smith C et al (2006) Use of inhaled corticosteroids and the risk of fracture. Chest 130:1082-1088
17. Weatherall M, James K, Clay J et al (2008) Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy 38:1451-1458
18. Pujades-Rodríguez M, Smith CJ, Hubbard RB (2007) Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease. QJM 100:509-517
19. Johnell O, Pauwels R, Lofdahl CG et al (2002) Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler. Eur Respir J 19:1058-1063
20. de Vries F, van Staa TP, Bracke MS (2005) Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 25:879-884
21. Etminan M, Sadatsafavi M, Ganjizadeh Zavareh S et al (2008) Inhaled corticosteroids and the risk of fractures in older adults: A systematic review and meta-analysis. Drug Saf 31:409-414
22. Boulet LP, Becker A, Bérubé D et al (1999) Canadian Asthma Consensus Report 1999 Canadian Asthma Consensus Group. CMAJ 161(Suppl 11):S1-S61
23. Suissa S, Ernst P (2004) Inhaled corticosteroids and fracture risk in COPD. Am J Respir Crit Care Med 170:194
24. Guglielmi G, Stoppino LP, Placentino MG et al (2009) Reproducibility of a semi-automatic method for 6-point vertebral morphometry in a multi-center trial. Eur J Radiol 69:173-178
25. Krieg MA, Barkmann R, Gonnelli S et al (2008) Quantitative ultrasound in the management of osteoporosis: The 2007 ISCD official positions. J Clin Densitom 11:163-187
26. Vestergaard P, Rejnmark L, Mosekilde L (2007) Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest 132:1599-1607
27. de Vries F, Pouwels S, Bracke M (2007) Use of beta-2 agonists and risk of hip/femur fracture: A population-based case-control study. Pharmacoepidemiol Drug Saf 16:612-619
28. Bonnet N, Benhamou CL, Brunet-Imbault B et al (2005) Severe bone alterations under beta2 agonist treatments: Bone mass, microarchitecture and strength analyses in female rats. Bone 37:622-633
29. Wiens M, Etminan M, Gill SS et al (2006) Effects of antihypertensive drug treatments on fracture outcomes: A meta-analysis of observational studies. J Intern Med 260:350-362
30. Gluer CC, for the International Quantitative Ultrasound Consensus Group (1997) Quantitative ultrasound techniques for the assessment of osteoporosis: Expert agreement on current status. J Bone Miner Res 12:1280-1288